May 5th 2025
The 2025 Community Oncology Conference empowered attendees with insights on advocacy, innovation, and practical strategies for enhancing community cancer care.
Dr Mitzi Joi Williams: CHIMES Data Fill Need for More Complete Picture of MS Diversity
April 21st 2023In several abstracts presented at this year's American Academy of Neurology Annual Meeting, Mitzi Joi Williams, MD, FAAN, Joi Life Wellness Neurology Clinic, explores multiple sclerosis–related outcomes in diverse patient populations.
Watch
T1D Plus Psychiatric Disorders May Influence Educational Outcomes
April 20th 2023Although children with type 1 diabetes (T1D) are slightly more likely to experience long-term educational underachievement than their peers without T1D, those who also have a psychiatric disorder have significantly lower odds of achieving educational milestones.
Read More
Dr Jessica Allegretti: Major Advancements Being Explored for Prevention, Treatment of CDI
April 18th 2023Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, reviews emerging therapeutics being investigated for the prevention and treatment of Clostridioides difficile infection (CDI).
Watch
PEA Leads to Long-term QOL Improvement in People With CTEPH, Study Suggests
April 17th 2023Most patients with chronic thromboembolic pulmonary hypertension (CTEPH) said they can go about their daily activities without restriction, the authors found, because of gains in functional status and quality of life (QOL).
Read More
Sacubitril/Valsartan Likely to Improve Pre-HFpEF Outcomes vs Valsartan Alone
April 13th 2023At present, there are no approved therapies for pre–heart failure with preserved ejection fraction (pre-HFpEF); instead, cardiovascular risk factor management is often utilized in this patient population.
Read More
Patients With PAH Accrue Higher Costs, HRU, Regardless of Etiology
April 10th 2023Patients with pulmonary arterial hypertension (PAH) related to connective tissue disorders (CTDs) and patients with PAH related to another condition accrued higher costs and higher health care resource use (HRU) vs patients who had CTD without PH.
Read More